NAGE Competitors & Alternatives
Compare Niagen Bioscience, Inc. with similar stocks in the same industry
Biotechnology
NAGE
Main Stock$3.43
Tradestie Score
55
Market Cap
$629.25M
P/E Ratio
15.9
Revenue Growth
0.0%
Analyst Upside
+267.3%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.83
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.51
|
$297.23M | - | 58 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.93
|
$293.03M | - | 64 | Compare |
|
OMER
Omeros Corporation
|
$9.28
|
$281.75M | 8.3 | 51 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.82
|
$275.54M | - | 55 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.08
|
$275.13M | - | 55 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$20.59
|
$269.08M | - | 57 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.89
|
$258.18M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$35.34
|
$256.54M | - | 64 | Compare |
More NAGE Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2833)
236 stocks in this industry